HF/Transplantation

Top Story

Poor 5-year survival rates underscore need for improved HF treatments

November 20, 2017

ANAHEIM, Calif. — Results among patients across the ejection fraction spectrum show similar poor 5-year survival and increased risk for CV and HF hospital admission, according to new data presented at the American Heart Association Scientific Sessions.

The data, simultaneously published in the Journal of the American College of Cardiology, highlighted the need for improvement in the treatment of patients with HF, according to Kevin S. Shah, MD, from the department of medicine and division of cardiology at the University of California, Los Angeles, and colleagues.

In the Journals PlusPerspective

Heart failure strongest predictor of poor survival in type 2 diabetes

November 17, 2017
Older adults with type 2 diabetes are at increased risk for death from cardiovascular complications, with the strongest associations found between survival and heart…
Meeting News

HOPE-Duchenne: Cell therapy shows promise for treating Duchenne cardiomyopathy

November 17, 2017
ANAHEIM, Calif. — Cardiosphere-derived cells to treat patients with cardiomyopathy caused by Duchenne muscular dystrophy was safe and well-tolerated, according to…
Meeting News

REDUCE LAP-HF: Interatrial shunt device lowers left atrial pressure in HFpEF

November 17, 2017
ANAHEIM, Calif. — A transcatheter interatrial shunt device reduced pulmonary capillary wedge pressure during exercise in people with HF and preserved ejection…
More Headlines »
Advertisement
Advertisement